Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease

Reviews in the Neurosciences

Volumn 22, Issue 3, 2011, Pages 285-294

  Bordji, Karim ^a   Becerril Ortega, Javier ^a   Buisson, Alain ^b  

^a CNRS   (France)

^b GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

Author keywords

Alzheimer's disease; amyloid precursor protein; amyloid ; calcium; memantine; NMDA receptors

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; APP PROTEIN, HUMAN;

ALZHEIMER DISEASE; BRAIN NERVE CELL; DEMENTIA; DRUG ACTIVITY; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; SYNAPSE; ANIMAL; BIOLOGICAL MODEL; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; HUMANS; MODELS, NEUROLOGICAL; NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES;

EID: 80051927442     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/RNS.2011.029     Document Type: Review

References (81)

1. Alley, G.M., Bailey, J.A., Chen, D., Ray, B., Puli, L.K., Tanila, H., Banerjee, P.K., and Lahiri D.K. (2010). Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice. J. Neurosci. Res. 88, 143-154.
2. Bordji, K., Becerril-Ortega, J., Nicole, O., and Buisson A. (2010). Activation of extrasynaptic, but not synaptic NMDA receptors modifi es amyloid precursor protein expression pattern and increases amyloid-βproduction. J. Neurosci. 30, 15927-15942.
3. Buckner, R.L., Snyder, A.Z., Shannon, B.J., LaRossa, G., Sachs, R., Fotenos, A.F., Sheline, Y.I., Klunk, W.E., Mathis, C.A., Morris, J.C., et al. (2005). Molecular, structural, and functional characterization of Alzheimer?s disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25, 7709-7717. (Pubitemid 41208641)
4. Caccamo, A., Oddo, S., Billings, L.M., Green, K.N., Martinez-Coria, H., Fisher, A., and LaFerla F.M. (2006). M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49, 671-682. (Pubitemid 43290127)
5. Cao, X. and Sudhof, T.C. (2001). A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120. (Pubitemid 32625507)
6. Caputi, A., Barindelli, S., Pastorino, L., Cimino, M., Buxbaum, J.D., Cattabeni, F., and Di Luca M. (1997). Increased secretion of the amino-terminal fragment of amyloid precursor protein in brains of rats with a constitutive up-regulation of protein kinase C. J. Neurochem. 68, 2523-2529. (Pubitemid 27218175)
7. Chen, H.S. and Lipton, S.A. (2006). The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 97, 1611-1626. (Pubitemid 43873656)
8. Chen, H.S., Pellegrini, J.W., Aggarwal, S.K., Lei, S.Z., Warach, S., Jensen, F.E., and Lipton S.A. (1992). Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci. 12, 4427-4436.
9. Choi, D.W. (1995). Calcium: still in the central stage in hypoxicischemic neuronal death. Trends Neurosci. 18, 58-60.
10. Choi, D.W., Koh, J.Y., and Peters S. (1988). Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8, 185-196. (Pubitemid 18038308)
11. Cirrito, J.R., Yamada, K.A., Finn, M.B., Sloviter, R.S., Bales, K.R., May, P.C., Schoepp, D.D., Paul, S.M., Mennerick, S., and Holtzman D.M. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913-922. (Pubitemid 41814696)
12. Cirrito, J.R., Kang, J.E., Lee, J., Stewart, F.R., Verges, D.K., Silverio, L.M., Bu, G., Mennerick, S., and Holtzman D.M. (2008). Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58, 42-51. (Pubitemid 351467029)
13. Citron, M. (2004). Strategies for disease modification in Alzheimer?s disease. Nat. Rev. Neurosci. 5, 677-685.
14. Francis, R., McGrath, G., Zhang, J., Ruddy, D.A., Sym, M., Apfeld, J., Nicoll, M., Maxwell, M., Hai, B., Ellis, M.C., et al. (2002). aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell 3, 85-97. (Pubitemid 34778398)
15. Garcia-Osta, A. and Alberini, C.M. (2009). Amyloid beta mediates memory formation. Learn. Mem. 16, 267-272.
16. Haass, C. (2004). Take fi ve-BACE and the gamma-secretase quartet conduct Alzheimer?s amyloid beta peptide generation. EMBO J. 23, 483-488. (Pubitemid 38282380)
17. Hardingham, G.E. (2006). Pro-survival signalling from the NMDA receptor. Biochem. Soc. Trans. 34, 936-938. (Pubitemid 44796454)
18. Hardingham, G.E. and Bading, H. (2010). Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682-696.
19. Hardingham, G.E., Fukunaga, Y., and Bading H. (2002). Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shutoff and cell death pathways. Nat. Neurosci. 5, 405-414. (Pubitemid 34454245)
20. Hardy, J. and Allsop, D. (1991). Amyloid deposition as the central event in the aetiology of Alzheimer?s disease. Trends Pharmacol. Sci. 12, 383-388.
21. Hardy, J. and Selkoe, D.J. (2002). The amyloid hypothesis of Alzheimer?s disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
22. Hetman, M. and Kharebava, G. (2006). Survival signalling pathways activated by NMDA receptors. Curr. Top. Med. Chem. 6, 787-799.
23. Hoey, S.E., Williams, R.J., and Perkinton M.S. (2009). Synaptic NMDA receptor activation stimulates secretase amyloid precursor protein processing and inhibits amyloid-βproduction. J. Neurosci. 29, 4442-4460.
24. Hussain, I., Powell, D., Howlett, D.R., Tew, D.G., Meek, T.D., Chapman, C., Gloger, I.S., Murphy, K.E., Southan, C.D., Ryan, D.M., et al. (1999). Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14, 419-427. (Pubitemid 30026585)
25. Ikonomidou, C. and Turski, L. (2002). Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury ? Lancet 1, 383-386. (Pubitemid 37159164)
26. Ivanov, A., Pellegrino, C., Rama, S., Dumalska, I., Salyha, Y., Ben-Ari, Y., and Medina I. (2006). Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. J. Physiol. 572, 789-798.
27. Johnson, J.W. and Kotermanski, S.E. (2006). Mechanism of action of memantine. Curr. Opin. Pharmacol. 6, 61-67. (Pubitemid 43103820)
28. Kamal, A., Stokin, G.B., Yang, Z., Xia, C.H., and Goldstein L.S. (2000). Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28, 449-459.
29. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., and Malinow R. (2003). APP processing and synaptic function. Neuron 37, 925-937. (Pubitemid 36398299)
30. Kang, J., Lemaire, H.G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.H., Multhaup, G., Beyreuther, K., and Müller-Hill B. (1987). The precursor of Alzheimer?s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736. (Pubitemid 17054046)
31. Kang, J.E., Lim, M.M., Bateman, R.J., Lee, J.J., Smyth, L.P., Cirrito, J.R., Fujiki, N., Nishino, S., and Holtzman D.M. (2009). Amyloid-beta dynamics are regulated by orexin and the sleepwake cycle. Science 326, 1005-1007.
32. Khachaturian, Z.S. (1987). Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol. Aging 8, 345-346.
33. Khachaturian, Z.S. (1989). Calcium, membranes, aging and Alzheimer?s disease. Introduction and overview. Ann. NY Acad. Sci. 568, 1-4.
34. Khachaturian, Z.S. (1994). Calcium hypothesis of Alzheimer?s disease and brain aging. Ann. NY Acad. Sci. 747, 1-11.
35. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., and Fahrenholz F. (1999). Constitutive and regulated alpha-secretase cleavage of Alzheimer?s amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 96, 3922-3927. (Pubitemid 29169012)
36. Lancelot, E. and Beal, M.F. (1998). Glutamate toxicity in chronic neurodegenerative diseases. Prog. Brain Res. 116, 331-347. (Pubitemid 28526944)
37. Lazarov, O., Robinson, J., Tang, Y.P., Hairston, I.S., Korade-Mirnics, Z., Lee, V.M., Hersh, L.B., Sapolsky, R.M., Mirnics, K., and Sisodia S.S. (2005). Environmental enrichment reduces A levels and amyloid deposition in transgenic mice. Cell 120, 701-713. (Pubitemid 40343081)
38. Leissring, M.A., Murphy, M.P., Mead, T.R., Akbari, Y., Sugarman, M.C., Jannatipour, M., Anliker, B., Müller, U., Saftig, P., De Strooper, B., et al. (2002). A physiologic signaling role for the secretase-derived intracellular fragment of APP. Proc. Natl. Acad. Sci. USA 99, 4697-4702. (Pubitemid 34286047)
39. Lesné , S., Ali, C., Gabriel, C., Croci, N., MacKenzie, E.T., Glabe, C.G., Plotkine, M., Marchand-Verrecchia, C., Vivien, D., and Buisson A. (2005). NMDA receptor activation inhibits secretase and promotes neuronal amyloid-βproduction. J. Neurosci. 25, 9367-9377. (Pubitemid 41464749)
40. Lé veillé , F., El Gaamouch, F., Gouix, E., Lecocq, M., Lobner, D., Nicole, O., and Buisson A. (2008). Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J. 22, 4258-4271.
41. Li, S., Hong, S., Shepardson, N.E., Walsh, D.M., Shankar, G.M., and Selkoe D. (2009). Soluble oligomers of amyloid-beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788-801.
42. Lipton, S.A. (2006). Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat. Rev. Neurosci. 5, 160-170.
43. Lipton, S.A. (2007). Pathologically activated therapeutics for neuroprotection. Nat. Rev. Neurosci. 8, 803-808. (Pubitemid 47462118)
44. Lipton, S.A. and Rosenberg, P.A. (1994). Mechanisms of disease: excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622.
45. Mackenzie, I.R. and Miller, L.A. (1994). Senile plaques in temporal lobe epilepsy. Acta Neuropathol. 87, 504-510. (Pubitemid 24128978)
46. Marcello, E., Gardoni, F., Mauceri, D., Romorini, S., Jeromin, A., Epis, R., Borroni, B., Cattabeni, F., Sala, C., Padovali, A., et al. (2007). Synapse-associated protein-97 mediates secretase ADAM10 trafficking and promotes its activity. J. Neurosci. 27, 1682-1691. (Pubitemid 46280085)
47. Mattson, M.P. (2004). Pathways towards and away from Alzheimer?s disease. Nature 430, 631-639. (Pubitemid 39061671)
48. Mattson, M.P., Cheng, B., Culwell, A.R., Esch, F.S., Lieberburg, I., and Rydel R.E. (1993). Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the betaamyloid precursor protein. Neuron 10, 243-254. (Pubitemid 23079546)
49. Mbebi, C., Sé e, V., Mercken, L., Pradier, L., Müller, U., and Loeffl er J.P. (2002). Amyloid precursor protein family-induced neuronal death is mediated by impairment of the neuroprotective calcium/calmodulin protein kinase IV-dependent signaling pathway. J. Biol. Chem. 277, 20979-20990. (Pubitemid 34967409)
50. Milnerwood, A.J., Gladding, C.M., Pouladi, M.A., Kaufman, A.M., Hines, R.M., Boyd, J.D., Ko, R.W., Vasuta, O.C., Graham, R.K., Hayden, M.R., et al. (2010). Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington?s disease mice. Neuron 65, 178-190.
51. Nishimoto, I., Okamoto, T., Matsuura, Y., Takahashi, S., Okamoto, T., Murayama, Y., and Ogata E. (1993). Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature 362, 75-79. (Pubitemid 23087295)
52. Nitsch, R.M., Deng, M., Tennis, M., Schoenfeld, D., and Growdon J.H. (2000). The selective muscarinic M1 agonist AF102B decreases levels of total Aβin cerebrospinal fluid of patients with Alzheimer?s disease. Ann. Neurol. 48, 913-918.
53. Okamoto, S., Pouladi, M.A., Talantova, M., Yao, D., Xia, P., Ehrnhoefer, D.E., Zaidi, R., Clemente, A., Kaul, M., Graham, R.K., et al. (2009). Balance between synaptic versus extrasynaptic NMDA receptor activity Influences inclusions and neurotoxicity of mutant huntingtin. Nat. Med. 15, 1407-1413.
54. Palop, J.J., Chin, J., Roberson, E.D., Wang, J., Thwin, M.T., Bien-Ly, N., Yoo, J., Ho, K.O., Yu, G.Q., Kreitzer, A., et al. (2007). Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer?s disease. Neuron 55, 697-711. (Pubitemid 47321079)
55. Papadia, S., Soriano, F.X., Lé veillé , F., Martel, M.A., Dakin, K.A., Hansen, H.H., Kaindl, A., Sifringer, M., Fowler, J., Stefovska,V., et al. (2008). Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat. Neurosci. 11, 476-487. (Pubitemid 351441886)
56. Parsons, C.G., Stöffl er, A., and Danysz W. (2007). Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology 53, 699-723. (Pubitemid 47532143)
57. Puzzo, D., Privitera, L., Leznik, E., Fa, M., Staniszewski, A., Palmeri, A., and Arancio O. (2008). Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci. 28, 14537-14545.
58. Qiu, W.Q., Ferreira, A., Miller, C., Koo, E.H., and Selkoe D.J. (1995). Cell-surface beta-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner. J. Neurosci. 15, 2157-2167.
59. Querfurth, H.W. and Selkoe, D.J. (1994). Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry 33, 4550-4561. (Pubitemid 24145103)
60. Rothman, S.M. and Olney, J.W. (1995). Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci. 18, 57-58.
61. Saitoh, T., Sundsmo, M., Roch, J.M., Kimura, N., Cole, G., Schubert, D., Oltersdorf, T., and Schenk D.B. (1989). Secreted form of amyloid beta protein precursor is involved in the growth regulation of fi broblasts. Cell 58, 615-622. (Pubitemid 19210955)
62. Sattler, R., Charlton, M.P., Hafner, M., and Tymianski M. (1998). Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J. Neurochem. 71, 2349-2364. (Pubitemid 28531245)
63. Scholtzova, H., Wadghiri, Y.Z., Douadi, M., Sigurdsson, E.M., Li, Y.S., Quartermain, D., Banerjee, P., and Wisniewski T. (2008). Memantine leads to behavioral improvement and amyloid reduction in Alzheimer?s-disease-model transgenic mice shown as by micromagnetic resonance imaging. J. Neurosci. Res. 86, 2784-2791.
64. Selkoe, D.J. (2001). Alzheimer?s disease: genes, proteins, and therapy. Physiol. Rev. 81, 741-766.
65. Selkoe, D.J. and Shenk, D. (2003). Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43, 545-584. (Pubitemid 37372653)
66. Shankar, G.M., Bloodgood, B.L., Townsend, M., Walsh, D.M., Selkoe, D.J., and Sabatini B.L. (2007). Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signalling pathway. J. Neurosci. 27, 2866-2875. (Pubitemid 46438992)
67. Skovronsky, D.M., Moore, D.B., Milla, M.E., Doms, R.W., and Lee V.M. (2000). Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-Golgi network. J. Biol. Chem. 275, 2568-2575. (Pubitemid 30082022)
68. Smith, I.F., Green, K.N., and LaFerla F.M. (2005). Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modifi ed animals. Cell Calcium 38, 427-437. (Pubitemid 41283281)
69. Song, M.S., Rauw, G., Baker, G.B., and Kar S. (2008). Memantine protects rat cortical cultured neurons against beta-amyloidinduced toxicity by attenuating tau phosphorylation. Eur. J. Neurosci. 28, 1989-2002.
70. Stanika, R.I., Pivovarova, N.B., Brantner, C.A., Watts, C.A., Winters, C.A., and Andrews S.B. (2009). Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc. Natl. Acad. Sci. USA 106, 9854-9859.
71. Steiner, H. and Haass, C. (2000). Intramembrane proteolysis by presenilins. Nat. Rev. Mol. Cell Biol. 1, 217-224.
72. Stern, Y. (2006). Cognitive reserve and Alzheimer disease. Alzheimer's Dis. Assoc. Disord. 20, S69-S74. (Pubitemid 44265854)
73. Stokin, G.B. and Goldstein, L.S. (2006). Axonal transport and Alzheimer?s disease. Annu. Rev. Biochem. 75, 607-627.
74. Stutzmann, G.E. (2005). Calcium dysregulation, IP3 signaling, and Alzheimer's disease. Neuroscientist 11, 110-115.
75. Tampellini, D. and Gouras, G.K. (2010). Synapses, synaptic activity and intraneuronal Aβin Alzheimer's disease. Front. Aging Neurosci. 2, 1-5.
76. Tampellini, D., Rahman, N., Gallo, E.F., Huang, Z., Dumont, M., Capetillo-Zarate, E., Ma, T., Zheng, R., Lu, B., Nanus, D.M., et al. (2009). Synaptic activity reduces intraneuronal Aβ, promotes APP transport to synapses, and protects against Aβ-related synaptic alterations. J. Neurosci. 29, 9704-9713.
77. Tanzi, R.E. and Bertram, L. (2005). Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120, 545-555. (Pubitemid 40269768)
78. Tymianski, M., Charlton, M.P., Carlen, P.L., and Tator C.H. (1993). Source Specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J. Neurosci. 13, 2085-2104. (Pubitemid 23113418)
79. Walsh, D.M. and Selkoe, D.J. (2007). Aβoligomers-a decade of discovery. J. Neurochem. 101, 1172-1184.
80. Waxman, E.A. and Lynch, D.R. (2005). N-methyl-D-aspartate receptors subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 11, 37-49. (Pubitemid 40223089)
81. Xia, P., Chen, H.S., Zhang, D., and Lipton S.A. (2010). Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J. Neurosci. 30, 11246-11250.